Dr. Jonathan A. Coleman

Dr. Jonathan A. Coleman, MD, is a widely respected urologic oncologist specializing in the surgical treatment of prostate, kidney, adrenal, and upper urinary tract cancers. He serves as an Attending Surgeon at Memorial Sloan Kettering Cancer Center and is an Associate Professor of Urology at Weill Cornell Medical College. Dr. Coleman earned his medical degree from Cornell University Medical College and completed his residency in urology and general surgery at NewYork-Presbyterian Hospital. He later completed a fellowship in urologic oncology at the National Cancer Institute. Board-certified in Urology, Dr. Coleman brings decades of clinical expertise to the management of complex genitourinary malignancies, with a focus on innovation and patient-centered care.

Dr. Coleman is widely recognized for his pioneering work in robotic and minimally invasive surgery, including robotic-assisted prostatectomy and laparoscopic partial nephrectomy. He has also advanced nonthermal tumor ablation techniques such as cryoablation and photodynamic therapy, aiming to preserve organ function while achieving optimal oncologic outcomes. His translational research focuses on upper tract urothelial carcinoma, renal cell carcinoma, and bladder cancer, integrating genomic profiling, immunotherapy, and patient-derived organoid models to personalize treatment strategies. He has authored numerous peer-reviewed publications and leads clinical trials exploring novel therapies and surgical technologies for urologic cancers.

In addition to his clinical and research leadership, Dr. Coleman is a respected educator and mentor who has trained numerous residents, fellows, and early-career physician-scientists. He is a frequent speaker at national and international conferences and plays an active role in shaping clinical guidelines for urologic oncology. Known for his clear communication, surgical precision, and compassionate care, Dr. Coleman is consistently recognized by patients and peers alike. Through his commitment to surgical excellence, scientific discovery, and academic mentorship, Dr. Coleman continues to shape the future of cancer care in urology.